Zelira Therapeutics Overview
- Year Founded
-
2003
- Status
-
Public
- Employees
-
8
- Stock Symbol
-
ZLD
- Investments
-
2
- Share Price
-
$0.47
- (As of Thursday Closing)
Zelira Therapeutics General Information
Description
Zelira Therapeutics Ltd is a biotechnology company focused on developing a range of cannabinoid-based formulations for the treatment of various medical conditions in Australia. The company is involved in a human clinical trial program focused on insomnia, autism, and eczema; and a pre-clinical research program to examine the effect of cannabinoids in breast, brain, and pancreatic cancer.
Contact Information
Website
www.zeliratx.comCorporate Office
- 101 Saint Georges Terrace
- Level 3
- Perth, Western Australia 6000
- Australia
Corporate Office
- 101 Saint Georges Terrace
- Level 3
- Perth, Western Australia 6000
- Australia
Zelira Therapeutics Stock Performance
(As of Thursday Closing)
| Stock Price | Previous Close | 52 wk Range | Market Cap | Shares | Average Volume | EPS |
|---|---|---|---|---|---|---|
| $0.47 | $0.47 | $0.19 - $0.74 | $5.33M | 11.3M | 6.4K | -$2.11 |
Zelira Therapeutics Financials Summary
|
In Thousands, USD |
TTM 30-Jun-2024 | FY 2024 30-Jun-2024 | FY 2023 30-Jun-2023 | FY 2022 30-Jun-2022 |
|---|---|---|---|---|
| EV | 3,485 | 3,485 | 11,475 | 5,181 |
| Revenue | 62 | 62 | 202 | 1,116 |
| EBITDA | (23,279) | (23,279) | (3,796) | (8,538) |
| Net Income | (23,965) | (23,965) | (3,747) | (8,656) |
| Total Assets | 3,465 | 3,465 | 22,433 | 25,935 |
| Total Debt | 3,976 | 3,976 | 290 | 345 |
Zelira Therapeutics Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Zelira Therapeutics Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
Zelira Therapeutics Patents
Zelira Therapeutics Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| AU-2020901947-A0 | Composition and method for treating chronic pain | Pending | 12-Jun-2020 |
Zelira Therapeutics Executive Team (7)
| Name | Title | Board Seat |
|---|---|---|
| Oludare Odumosu Ph.D | Managing Director, Global Chief Executive Officer & Board Member | |
| Jason Peterson | Co-Founder and Director | |
| Stewart Washer | Co-Founder and Director | |
| Rahul Ganesan | Vice President, Finance & Accounting | |
| Mara Gordon | Co-Founder & Board Member |
Zelira Therapeutics Board Members (2)
| Name | Representing | Role | Since |
|---|---|---|---|
| Self | Co-Founder & Board Member | ||
| Self | Chairman |
Zelira Therapeutics Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
Zelira Therapeutics Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|
Zelira Therapeutics Acquisitions (2)
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| Ilera Therapeutics | 01-Dec-2019 | Pharmaceuticals | |||
| Gleneagle Gold | 30-Oct-2016 | Merger/Acquisition | Gold Mining |
Zelira Therapeutics FAQs
-
When was Zelira Therapeutics founded?
Zelira Therapeutics was founded in 2003.
-
Who is the founder of Zelira Therapeutics?
Jason Peterson, Stewart Washer, Harry Karelis, and Mara Gordon are the founders of Zelira Therapeutics.
-
Who is the CEO of Zelira Therapeutics?
Oludare Odumosu Ph.D is the CEO of Zelira Therapeutics.
-
Where is Zelira Therapeutics headquartered?
Zelira Therapeutics is headquartered in Perth, Australia.
-
What is the size of Zelira Therapeutics?
Zelira Therapeutics has 8 total employees.
-
What industry is Zelira Therapeutics in?
Zelira Therapeutics’s primary industry is Pharmaceuticals.
-
Is Zelira Therapeutics a private or public company?
Zelira Therapeutics is a Public company.
-
What is Zelira Therapeutics’s stock symbol?
The ticker symbol for Zelira Therapeutics is ZLD.
-
What is the current stock price of Zelira Therapeutics?
As of 10-Oct-2024 the stock price of Zelira Therapeutics is $0.47.
-
What is the current market cap of Zelira Therapeutics?
The current market capitalization of Zelira Therapeutics is $5.33M.
-
What is Zelira Therapeutics’s current revenue?
The trailing twelve month revenue for Zelira Therapeutics is $62.2K.
-
What is Zelira Therapeutics’s annual earnings per share (EPS)?
Zelira Therapeutics’s EPS for 12 months was -$2.11.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »
